Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity

v3.24.2
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022   78,745      
Balance at beginning of period at Dec. 31, 2022 $ 676,385 $ 8 $ 722,778 $ (1,021) $ (45,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,236      
Common stock issued pursuant to equity awards, net 31,926   31,926    
Stock-based compensation 16,460   16,460    
Other comprehensive loss (192)     (192)  
Net income (loss) 9,533       9,533
Balance at end of period (in shares) at Mar. 31, 2023   79,981      
Balance at end of period at Mar. 31, 2023 734,112 $ 8 771,164 (1,213) (35,847)
Balance at beginning of period (in shares) at Dec. 31, 2022   78,745      
Balance at beginning of period at Dec. 31, 2022 676,385 $ 8 722,778 (1,021) (45,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 5,182        
Balance at end of period (in shares) at Jun. 30, 2023   80,930      
Balance at end of period at Jun. 30, 2023 746,047 $ 8 788,528 (2,291) (40,198)
Balance at beginning of period (in shares) at Mar. 31, 2023   79,981      
Balance at beginning of period at Mar. 31, 2023 734,112 $ 8 771,164 (1,213) (35,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   808      
Common stock issued pursuant to equity awards, net (2,752)   (2,752)    
Employee stock purchase plan (in shares)   141      
Employee stock purchase plan 2,989   2,989    
Stock-based compensation 17,127   17,127    
Other comprehensive loss (1,078)     (1,078)  
Net income (loss) (4,351)       (4,351)
Balance at end of period (in shares) at Jun. 30, 2023   80,930      
Balance at end of period at Jun. 30, 2023 $ 746,047 $ 8 788,528 (2,291) (40,198)
Balance at beginning of period (in shares) at Dec. 31, 2023 81,818 81,818      
Balance at beginning of period at Dec. 31, 2023 $ 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,249      
Common stock issued pursuant to equity awards, net 8,777   8,777    
Stock-based compensation 17,032   17,032    
Other comprehensive loss (1,782)     (1,782)  
Net income (loss) (72,309)       (72,309)
Balance at end of period (in shares) at Mar. 31, 2024   83,067      
Balance at end of period at Mar. 31, 2024 $ 637,983 $ 8 834,384 (5,573) (190,836)
Balance at beginning of period (in shares) at Dec. 31, 2023 81,818 81,818      
Balance at beginning of period at Dec. 31, 2023 $ 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (111,575)        
Balance at end of period (in shares) at Jun. 30, 2024 83,898 83,898      
Balance at end of period at Jun. 30, 2024 $ 617,255 $ 8 853,865 (6,516) (230,102)
Balance at beginning of period (in shares) at Mar. 31, 2024   83,067      
Balance at beginning of period at Mar. 31, 2024 637,983 $ 8 834,384 (5,573) (190,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   655      
Common stock issued pursuant to equity awards, net (545)   (545)    
Employee stock purchase plan (in shares)   176      
Employee stock purchase plan 2,682   2,682    
Stock-based compensation 17,344   17,344    
Other comprehensive loss (943)     (943)  
Net income (loss) $ (39,266)       (39,266)
Balance at end of period (in shares) at Jun. 30, 2024 83,898 83,898      
Balance at end of period at Jun. 30, 2024 $ 617,255 $ 8 $ 853,865 $ (6,516) $ (230,102)